TABLE 2.
The role of cannabinoid receptor ligands in regulating tumor cells and bone diseases in vitro and in vivo.
Ligand | Receptor | Bone tumor | |||
---|---|---|---|---|---|
Tm.Growth | Osteolysis | Pain | |||
Agonists | AEA | CB1/CB2/GPR55/TRPV1 | ↓↓ | - | ↓ |
2-AG | CB1/CB2/GPR55 | ↓ | ↓ | - | |
Δ9-THC | CB1/CB2 | ↓↓↑↑ | - | ↓ | |
CP55,940 | CB1/CB2 | ↓ | - | ||
WIN55,212 | CB1 | ↓↓ | - | ||
HU308 | CB2 | ↑↓ | ↑ | - | |
JWH133 | CB2 | ↑↓↓ | ↓↓↑ | ||
JWH139 | CB2 | ↓ | - | ||
JWH015 | CB2 | ↓↓ | ↓ | ↓ | |
AM1241 | CB2 | ↓ | ↓ | ||
Lysophosphatidyl inositol | GPR55 | - | - | - | |
O-1602 | GPR55 | - | - | ||
Antagonists | AM630 | CB2>CB1/GPR55 | - | ↓ | |
SR144528 | CB2>CB1 | - | - | ||
AM251 | CB1>CB2/GPR55 | - | - | ||
SR141716A | CB1>CB2 | - | - | ||
Cannabidiol | GPR55 | ↓↓ | - | ↓ |
Abbreviations: CB1, cannabinoid type 1 receptor; CB2, cannabinoid type 2 receptor; GPR55, G protein-coupled receptor 55; TRPV1, transient receptor potential vanilloid type 1. Tm., tumor cell. ↑, increase; ↓, decrease; –, non tested. Black and red arrows denote in vitro and in vivo data, respectively.